Status:

COMPLETED

Comparison of Efficacy, Safety and Tolerability of Two Different 810 nm Diode Lasers for Hair Reduction

Lead Sponsor:

University of California, Irvine

Conditions:

Hypertrichosis

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

The purpose of this research study is to compare two different 810 diode laser systems (Soprano XL (SHR Mode)and Light Sheer Duet) for laser hair removal. The goal is to determine if each laser system...

Detailed Description

This side-by-side split body, blinded, randomized single-center study is comparing two different 810 nm diode laser technologies for the purpose of permanent hair reduction to determine the effectiven...

Eligibility Criteria

Inclusion

  • Subjects must be at least 18 years of age.
  • Subjects must be in reasonably good health as defined by the Investigator.
  • Subject agrees to avoid tanning during their participation in this trial.
  • Subject has Fitzpatrick skin types I-V and dark brown hair.
  • Subjects must agree to avoid shaving legs less than 72 hours prior to a study visit.
  • Subjects have indicated willingness to participate in the study by signing an informed consent document.

Exclusion

  • Subject is pregnant, lactating, or planning to get pregnant within the study period.
  • Subject is unwilling to use birth control during the study period if of child bearing age.
  • Subject has a known history of photosensitivity or use of medication with photosensitizing properties.
  • Subject has skin disease on exam at screening.
  • Subject has history or evidence of any chronic or reoccurring skin disease or disorder(e.g., psoriasis, Netherton syndrome, etc.) affecting the treatment area.
  • Subject has a history of keloid or hypertrophic scar formation.
  • Subject has a tattoo in the treatment area.
  • Subject has been tanning within the past 30 days.
  • Subject has history of confounding cancerous or pre-cancerous skin lesions in the treatment area.
  • Subject has used prohibited therapies (electrolysis, threading, waxing, depilatory), prohibited oral prescription medications (isotretinoin, steroids), or prohibited topical meds (steroids) on the treatment area within 30 days prior to enrollment.
  • Subject is unwilling to discontinue use of above listed prohibitive therapies for the duration of treatment.
  • Subject has a history of laser hair removal in the treatment area.
  • Subject has participated in any clinical trial involving an investigational drug or cosmetic product or procedure within the past 30 days.
  • The investigator feels that for any reason the subject is not eligible to participate in the study.
  • \-

Key Trial Info

Start Date :

September 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2013

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT01212172

Start Date

September 1 2010

End Date

September 1 2013

Last Update

February 5 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Dermatology Clinical Research

Irvine, California, United States, 92697

Comparison of Efficacy, Safety and Tolerability of Two Different 810 nm Diode Lasers for Hair Reduction | DecenTrialz